CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...